Patient focus; strong pipeline; great science; positive culture; very experienced, supportive, and empowering leadership that listens to the employees.
Cons
It would like to have more face to face time together with my colleagues.
Candel has ongoing clinical trials from phase 1 through phase 3 involving oncolytic virus immunotherapy platforms so it is a very dynamic place to be. Paul Peter is a knowledgeable and experienced CEO who communicates clearly to set the vision and provide inspiration. The company has a strong leadership team who sets strategies and clear goals for teams. The culture at Candel is friendly and collegial and the teams are hard-working and motivated to help patients - it is a great place to work.
Cons
The office is not located in the Cambridge hub (maybe that is a good thing?)